Insulin resistance and lipids in hypertensive women on hormone replacement therapy

Blood Pressure

Volumn 11, Issue 1, 2002, Pages 28-34

  Kawecka Jaszcz, Kalina ^a   Czarnecka, Danuta ^a   Dembińska Kieć, Aldona ^a   Olszanecka, Agnieszka ^a   Zdzienicka, Anna ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Hypertension; Insulin resistance; Lipid profile; Menopause

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; GLUCOSE; INSULIN; NORETHISTERONE ACETATE; THIAZIDE DIURETIC AGENT; LIPID;

ADULT; ARTICLE; BLOOD PRESSURE; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DYSLIPIDEMIA; ESTROGEN DEFICIENCY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULINEMIA; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; MIDDLE AGED;

BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; CHOLESTEROL; DRUG THERAPY, COMBINATION; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LIPIDS; MIDDLE AGED;

EID: 0036194802     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370502753543936     Document Type: Article

References (26)

1. Banting lecture: Role of insulin resistance in human disease
2. Insulin resistance in the pathogenesis of dyslipidemia
3. High density lipoprotein turnover in patients with essential hypertension
4. Prevalence of insulin resistance in essential hypertension
5. Prevalence of hyperinsulinemia in patients with high blood pressure
6. Hyperinsulinemia inhibits myocardial protein degradation in patients with cardiovascular disease and insulin resistance
7. The effects of menopause on insulin sensitivity, secretion and elimination in nonobese, healthy women
8. Cardiovascular health and disease in women
9. Relationship between the plasma insulin response to oral glucose and insulin stimulated glucose utilization in normal subjects
10. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
11. Effects of oral and transdermal 17 beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women
12. Differential effect of transdermal estrogen plus progestagen replacement therapy on insulin metabolism in postmenopausal women: Relation to their insulinemic secretion
13. The effects of transdermal 17-beta estradiol on glucose metabolism of postmenopausal women is evident during oral but not the intravenous glucose administration
14. The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women
15. Insulin sensitivity during postmenopausal hormone replacement with transdermal estradiol and intauterine levonorgestrel
16. Effects of hormone replacement therapy on glucose metabolism
17. Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal women
18. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women
19. The effect of estradiol and combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women
20. Insulin resistance, secretion and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy
21. Influence of continuous combined estradiol-norethisterone acetate praparations on insulin sensitivity in postmenopausal nondiabetic women
22. The effect on hormone replacement therapy on blood pressure and cardiovascular risk factors in menopausal women with moderate hypertension
23. Double-blind randomized controlled study of transdermal estrogen replacement therapy on hypertensive postmenopausal women
24. Hormone replacement therapy and blood pressure in hypertensive women
25. Estradiol-17β reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension